Carugno, A., Raponi, F., Locatelli, A., Vezzoli, P., Gambini, D., Di Mercurio, M., . . . Sena, P. (2020). No evidence of increased risk for Coronavirus Disease 2019 (COVID‐19) in patients treated with Dupilumab for atopic dermatitis in a high‐epidemic area – Bergamo, Lombardy, Italy. J Eur Acad Dermatol Venereol.

Carugno, A., F. Raponi, A.G Locatelli, P. Vezzoli, D.M Gambini, M. Di Mercurio, E. Robustelli Test, και P. Sena. "No Evidence of Increased Risk for Coronavirus Disease 2019 (COVID‐19) in Patients Treated With Dupilumab for Atopic Dermatitis in a High‐epidemic Area – Bergamo, Lombardy, Italy." J Eur Acad Dermatol Venereol 2020.

Carugno, A., et al. "No Evidence of Increased Risk for Coronavirus Disease 2019 (COVID‐19) in Patients Treated With Dupilumab for Atopic Dermatitis in a High‐epidemic Area – Bergamo, Lombardy, Italy." J Eur Acad Dermatol Venereol 2020.